8-KLeadership ChangesShareholder MattersExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Executive Changes (May 6, 2022)

Filed May 6, 2022For Securities:BSX

Summary

Boston Scientific Corporation filed an 8-K on May 6, 2022, detailing key updates from its Annual Meeting of Stockholders and changes to executive compensation. At the Annual Meeting held on May 3, 2022, all ten director nominees were elected for a one-year term, the advisory vote on executive compensation (Say-on-Pay) was approved, and Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year 2022. Additionally, the amendment and restatement of the Company's 2006 Global Employee Stock Ownership Plan, now named the Employee Stock Purchase Plan, was approved, including the addition of 10,000,000 shares. The company's Executive Compensation and Human Resources Committee also modified the Change in Control Agreements for executive officers (below CEO level). The revised agreements will provide for a cash severance payment of two times base salary and bonus, a reduction from the previous three times, aiming to better align compensation with stockholder value in the event of a change in control.

Key Highlights

  • 1All ten director nominees were elected to the Board for a one-year term.
  • 2Stockholders approved the advisory vote on executive compensation (Say-on-Pay).
  • 3Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year 2022.
  • 4The Company's Employee Stock Purchase Plan was amended and restated, with an additional 10,000,000 shares added.
  • 5Change in Control Agreements for executive officers (below CEO) were modified.
  • 6Revised Change in Control Agreements will provide cash severance of two times base salary and bonus, down from three times.
  • 7The modifications to Change in Control Agreements aim to better align executive compensation with stockholder value post-acquisition.

Frequently Asked Questions

The Annual Meeting saw the election of all director nominees, approval of the Say-on-Pay advisory vote on executive compensation, ratification of the independent auditors (Ernst & Young LLP), and approval of the amended and restated Employee Stock Purchase Plan, which includes an additional 10,000,000 shares.

The Executive Compensation and Human Resources Committee approved modifications to the Change in Control Agreements for executive officers below the CEO level. The key change is a reduction in the cash severance payout to two times the executive's base salary and bonus, down from the previous three times, intended to better align compensation with stockholder interests in a change of control scenario.

The amendment and restatement of the employee stock plan, now called the Employee Stock Purchase Plan, alongside the addition of 10,000,000 shares, suggests the company is continuing to support employee equity participation and potentially expanding the pool of shares available for such programs.

No, the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the 2022 fiscal year was ratified by the stockholders, indicating continuity in their external audit relationship.